摘要
相关案例报道证明了吸入、经皮、滴鼻、关节内和眼睛注射糖皮质激素有可能引起威胁生命的肾上腺功能不全。随着很少、有时相互矛盾的数据和研究方法,肾上腺功能不全引发于局部应用糖皮质激素的广泛性还不清楚。肾上腺功能不全只能通过刺激测试来正确评估,有报道证实40-50%患者接受大剂量吸入糖皮质激素。中到低剂量吸入糖皮质激素导致0-16%患者的肾上腺抑制。在使用规定剂量内糖皮质激素乳霜和鼻腔糖皮质激素也会引起肾上腺功能不全,但概率低于吸入糖皮质激素。关节腔单注射糖皮质激素后可引起肾上腺抑制。局部应用糖皮质激素的系统性效应取决于特定的糖皮质激素的药代动力学和动态属性以及个人因素。许多肾上腺机能不全的症状是不明确的,且往往难以区分于潜在的疾病症状。症状可能比普遍认为的和临床实践诊断下的更常见。潜在的肾上腺机能不全必须始终被接受各种形式糖皮质激素治疗的患者所牢记。临床上的要点和病人管理在病例报告和文献综述的基础上被讨论。更多的工作用于评估肾上腺机能不全的发生是由局部应用糖皮质激素引发仍然迫切苏维需要。
关键词: 肾上腺功能不全,糖皮质激素,下丘脑-垂体-肾上腺轴功能,吸入皮质激素,鼻类固醇,局部皮质类固醇。
Current Medicinal Chemistry
Title:Adrenal Insufficiency Caused by Locally Applied Glucocorticoids-Myth or Fact?
Volume: 22 Issue: 23
Author(s): Stina Willemoes Borresen, Marianne Klose, Ase Krogh Rasmussen and Ulla Feldt-Rasmussen
Affiliation:
关键词: 肾上腺功能不全,糖皮质激素,下丘脑-垂体-肾上腺轴功能,吸入皮质激素,鼻类固醇,局部皮质类固醇。
摘要: Case-reports have made it evident that both inhaled, percutaneous, intranasal, intraarticular and ophthalmic administered glucocorticoids have the potential to cause life threatening adrenal insufficiency. With few and sometimes conflicting data and study methodology the prevalence of adrenal insufficiency secondary to locally applied glucocorticoids is not clear. Adrenal insufficiency can only be correctly evaluated by a stimulation test, and has by this procedure been reported in up to 40-50% of patients treated with high-dose inhaled glucocorticoids. Medium- to low-dose inhaled glucocorticoids have been shown to cause adrenal suppression in 0-16% of patients. Glucocorticoid creams and nasal glucocorticoids can cause adrenal insufficiency, also when used within prescribed doses, but the frequency seems to be less than with inhaled glucocorticoids. Intraarticularly administered glucocorticoids can cause adrenal suppression after a single injection. The systemic effect of locally applied glucocorticoids depends on pharmacokinetic and –dynamic properties of the particular glucocorticoid as well as individual factors. Many of the symptoms in iatrogen adrenal insufficiency are unspecific and often difficult to differentiate from symptoms of underlying disease activity. The condition might therefore be more common than widely believed and underdiagnosed in clinical practice. Potential adrenal insufficiency must therefore always be kept in mind in patients treated with all forms of glucocorticoids. Clinically important points and patient management are discussed on the basis of a case report and review of the literature. More work assessing the prevalence of adrenal insufficiency secondary to locally applied glucocorticoids is urgently needed.
Export Options
About this article
Cite this article as:
Stina Willemoes Borresen, Marianne Klose, Ase Krogh Rasmussen and Ulla Feldt-Rasmussen , Adrenal Insufficiency Caused by Locally Applied Glucocorticoids-Myth or Fact?, Current Medicinal Chemistry 2015; 22 (23) . https://dx.doi.org/10.2174/0929867322666150716113003
DOI https://dx.doi.org/10.2174/0929867322666150716113003 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Why and How We Should Treat Elderly Patients with Hypertension?
Current Vascular Pharmacology Molecular Mechanisms of Biological Activity of Oleanolic Acid - A Source of Inspiration for A New Drugs Design
Mini-Reviews in Organic Chemistry A2A Adenosine Receptor and its Modulators: Overview on a Druggable GPCR and on Structure-Activity Relationship Analysis and Binding Requirements of Agonists and Antagonists
Current Pharmaceutical Design Nose to Brain Delivery of Nanoformulations for Neurotherapeutics in Parkinson’s Disease: Defining the Preclinical, Clinical and Toxicity Issues
Current Drug Delivery Pathways Related to the Anti-Cancer Effects of Metabolites Derived from Cerrado Biome Native Plants: An Update and Bioinformatics Analysis on Oral Squamous Cell Carcinoma
Protein & Peptide Letters An Overview on Natural Cholinesterase Inhibitors - A Multi-Targeted Drug Class - and Their Mass Production
Mini-Reviews in Medicinal Chemistry Postoperative Atrial Fibrillation - What Do We Really Know?
Current Vascular Pharmacology Guanylation of Amines with Isonitriles in the Presence of Iodine
Letters in Organic Chemistry Nutraceutical Approach to Peripheral Neuropathies: Evidence from Clinical Trials
Current Drug Metabolism NO News is not Necessarily Good News in Cancer
Current Cancer Drug Targets Relationship Between the Pharmacokinetics of Levosimendan and Its Effects on Cardiovascular System
Current Drug Metabolism Polyphenols: A Nutraceutical Approach Against Diseases
Recent Patents on Food, Nutrition & Agriculture Proteinase Inhibitors: A Promising Drug Class for Treating Leishmaniasis
Current Drug Targets Decreasing Arterial Aging by Controlling Blood Pressure Levels and Hypertension: A Step Forward
Current Vascular Pharmacology Safety of Systemic Biologic Agents in the Treatment of Non-malignant Skin Disorders
Current Drug Safety What is Currently the Best Radiopharmaceutical for the Hybrid PET/CT Detection of Recurrent Medullary Thyroid Carcinoma?
Current Radiopharmaceuticals TiO2-Nanowired Delivery of Mesenchymal Stem Cells Thwarts Diabetes- Induced Exacerbation of Brain Pathology in Heat Stroke: An Experimental Study in the Rat Using Morphological and Biochemical Approaches
CNS & Neurological Disorders - Drug Targets Perioperative Management of Hyperlipidemia Medications
Current Clinical Pharmacology Device-based Therapies for Resistant Hypertension
Current Pharmaceutical Design Subject Index To Volume 6
Endocrine, Metabolic & Immune Disorders - Drug Targets